From Gym Bags to Boardrooms
Drew Dible, a 31-year-old pharmacist in Missouri, spends his mornings measuring five grams of creatine monohydrate into a glass of water. Unlike the bodybuilders who popularized the substance decades ago, Dible is not chasing a larger bench press. He is chasing mental clarity. He views his daily dose as a hedge against the inevitable decline of cognitive function that often marks a person's 30s. Dible represents a growing demographic that looks at creatine not as a tool for muscle growth, but as a potential piece of long-term brain health.
The shift in perspective is driven largely by popular media and influential figures who have transitioned creatine into the mainstream wellness market. Since 2021, high-profile wellness figures like Andrew Huberman have broadcasted claims regarding the cognitive virtues of the supplement. These claims range from memory enhancement to the mitigation of symptoms related to concussions and depression. As a result, companies like Momentous, Thorne, and Onnit now market creatine as a cornerstone of cognitive performance rather than a crude tool for size.
The Evolution of Reputation
Creatine monohydrate entered the commercial market in 1993, long before the industry had reliable third-party testing or strict regulatory oversight. In those early years, it was frequently linked to rumors of kidney damage and liver toxicity. Some outlets even suggested a connection between the supplement and athlete deaths, though later investigations cleared the substance of those specific charges. Despite the bad press, the supplement persisted on the fringes of strength sports. It was a product for lifters, not the general public.
Today, the scientific understanding has moved past those initial fears. Researchers like Darren Candow at the University of Regina and Richard Kreider at Texas A&M have spent decades studying the long-term safety of the compound. Their work indicates that the concerns surrounding kidney and liver health were largely unfounded. By 2007, the International Society of Sports Nutrition formally recognized creatine as a safe and effective dietary aid. This validation provided the foundation for the current market boom, which saw a 120 percent sales increase at The Vitamin Shoppe in 2023.
Scientific Reality Versus Hype
While the market expands, the clinical data presents a more measured picture. A 2024 meta-analysis published in Frontiers in Nutrition found potential benefits for memory and attention, particularly in cases involving sleep deprivation. However, the mechanism of action remains specific. The brain consumes roughly 20 percent of the body's energy, relying on ATP to function effectively. Because creatine plays a critical role in the production of ATP, it is biologically plausible that supplemental intake could support brain activity under high-stress conditions.
That said, experts caution against the assumption that everyone will see an improvement. Peter Robinson, a clinical assistant professor of neurology at The Ohio State University, notes that much of the existing research demonstrates significant effects primarily in those who are already deficient in creatine. These groups include vegans, the elderly, and those suffering from chronic fatigue or sleep loss. For a healthy, well-nourished individual, the promise of transforming into a higher-functioning person remains unsupported by current data.
Looking Ahead
As the industry projects a global market value of $923 million by 2033, the divide between marketing promises and clinical outcomes continues to widen. Consumers are now offered creatine in gummies, bars, and energy drinks, often without clear labeling regarding the exact dosage provided. Because these products often lack third-party verification for purity, athletes in particular remain at risk of consuming tainted batches.
Moving forward, the focus will likely remain on whether these cognitive benefits are replicable in the general population. While proponents argue that creatine should be treated as a standard daily supplement like a multivitamin, the scientific community suggests a more conservative approach. Individuals interested in the substance should stick to the proven form of monohydrate and ensure they seek out third-party certified brands. The goal is to separate the tangible physical benefits from the speculative cognitive marketing as the industry continues its growth.